This year's cruise was our largest since 2007, with more than 150 cabins sold and over 320 attendees, including spouses, families, and guests. Among them were 120 registered plastic surgeons, including 15 current and past leaders of both the Society and Foundation. Our faculty featured 37 distinguished subject matter experts, eight of whom were first-time cruise speakers, and attendees represented ten different countries.
In this month’s update, Dr. Tracy Pfeifer highlights all the doctors who volunteer to help surgeons reach their goals, being up to date on cybersecurity, and the upcoming The MEET 2026 in Boston!
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
The recent Facial and Rhinoplasty Symposium was a tremendous success – and a great example of how The Society is evolving to meet the needs of our members and the demands of a fast-changing industry.